Skip to content

Trimas TRS Preferred Stock

Preferred Stock at other companies

Crown Holdings logo
Crown HoldingsCCK
$0
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$0
Dover logo
DoverDOV
$0
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
$0
LEC
Lincoln Electric HoldingsLECO
$0

Other financials

Income statement

See full
Revenue$168.3M+10.4%
Gross profit$36.9M+12.3%
Operating income$6.9M-3.6%
Net income$800.8M+6,348%
EPS (diluted)$21.40+7,033%

Balance sheet

See full
Cash & equivalents$1.3B+3,904%
Total debt$439.9M-9.2%
Total equity$1.4B+111%
Total assets$2.3B+64.8%

Cash flow

See full
Operating cash flow-$19.4M-311%
CapEx$5.2M-59.7%
Free cash flow-$24.6M-556%

Valuation

See full
Market cap$1.56B+41.9%
Enterprise value$692.33M-65.6%
P/E1.7×-33.2×
P/S2.4×+0.6×

Profitability

See full
Gross margin-0.1%-2.1pp
Operating margin8%-1.0pp
Net margin137.3%+132pp
FCF margin7.3%+3.1pp

Returns & leverage

See full
Return on equity85.1%+80.4pp
Debt / equity0.3×-0.4×
Current ratio4.9×+2.0×

Where this comes from

Reported directly by Trimas in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Trimas’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trimas's preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trimas's preferred stock?
Trimas (TRS) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.